🙄 harto de que digan que las medicinas para el TDAH ¨causan adicción¨ cuando es lo contrario #tdah #neurodivergencia #tdahadulto #neurodivergente #noerapenal Chang, Z., Lichtenstein, P., Halldner, L., D’Onofrio, B., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2014). Stimulant ADHD medication and risk for substance abuse. Journal of Child Psychology and Psychiatry, 55(8), 878–885. https://doi.org/10.1111/jcpp.12164 Groenman, A. P., Oosterlaan, J., Rommelse, N. N. J., Franke, B., Roeyers, H., Oades, R. D., Sergeant, J. A., Buitelaar, J. K., & Faraone, S. V. (2013). Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder. The British Journal of Psychiatry, 203(2), 112–119. https://doi.org/10.1192/bjp.bp.112.124784 Molina, B. S. G., Kennedy, T. M., Howard, A. L., et al. (2023). Association between stimulant treatment and substance use through adolescence into early adulthood. JAMA Psychiatry, 80(9), 933–941. https://doi.org/10.1001/jamapsychiatry.2023.2157 Quinn, P. D., Chang, Z., Hur, K., Gibbons, R. D., Lahey, B. B., Rickert, M. E., Sjölander, A., Lichtenstein, P., Larsson, H., & D’Onofrio, B. M. (2017). ADHD medication and substance-related problems. American Journal of Psychiatry, 174(9), 877–885. https://doi.org/10.1176/appi.ajp.2017.16060686 Schoenfelder, E. N., Faraone, S. V., & Kollins, S. H. (2014). Stimulant treatment of ADHD and cigarette smoking: A meta-analysis. Pediatrics, 133(6), 1070–1080. https://doi.org/10.1542/peds.2014-0179 Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003). Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics, 111(1), 179–185. https://doi.org/10.1542/peds.111.1.179
0.0% ERengagement of this clip — above the author's average (0.00%)
top 70%outperforms 30% of the author's clips
29%of the author's average views
